BridgeBio Pharma Inc
NASDAQ:BBIO
BridgeBio Pharma Inc
NASDAQ:BBIO
Price:
67.33
USD
2.83%
Market Closed
Market Cap:
$13.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
US |
|
Data Storage Corp
NASDAQ:DTST
|
US |
|
Worldline SA
OTC:WWLNF
|
FR |
|
G
|
Gorilla Technology Group Inc
NASDAQ:GRRR
|
KY |
Wall St Price Targets
BBIO Price Targets Summary
BridgeBio Pharma Inc
BridgeBio Pharma Inc
Wall Street analysts forecast BBIO stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for BBIO is 105.41 USD with a low forecast of 80.8 USD and a high forecast of 164.85 USD.
Lowest Forecast
Price Target
80.8
USD
20% Upside
Average Forecast
Price Target
105.41
USD
57% Upside
Highest Forecast
Price Target
164.85
USD
145% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BBIO's stock price target?
Price Target
105.41
USD
105.41
USD
According to Wall Street analysts, the average 1-year price target for BBIO is 105.41 USD with a low forecast of 80.8 USD and a high forecast of 164.85 USD.
What is the Revenue forecast for BridgeBio Pharma Inc?
Projected CAGR
37%
37%
The compound annual growth rate for Revenue over the next 8 years is 37%.
